Natural history of C282Y homozygotes for hemochromatosis

Canadian Journal of Gastroenterology

Volumn 16, Issue 5, 2002, Pages 297-302

  Wojcik, John P ^a   Speechley, Mark R ^a   Kertesz, Ann E ^a   Chakrabarti, Subrata ^a   Adams, Paul C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Genetic testing; Hemochromatosis; HFE gene; Iron

Indexed keywords

FERRITIN; INSULIN; IRON; ORAL ANTIDIABETIC AGENT; TRANSFERRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; HEALTH CARE FACILITY; HEART DISEASE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHLEBOTOMY; PRIORITY JOURNAL; SEX RATIO; SURVIVAL RATE; SYMPTOMATOLOGY;

EID: 0036334675     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/161569     Document Type: Article

References (33)

1. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis
2. Hemochromatosis and HLA-H
3. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
4. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
5. Phenotypic expression of HFE mutations: A French study of 1110 unrelated iron-overloaded patients and relatives
6. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation
7. Hemochromatosis and HLA-H
8. Hereditary hemochromatosis: Gene discovery and its implications for population-based screening
9. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in hemochromatosis
10. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis
11. Life tables, Canada and provinces 1990-1992
12. Population screening for hemochromatosis: A comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5,211 voluntary blood donors
13. Long-term survival analysis in hereditary hemochromatosis
14. Clinically overt hemochromatosis in Denmark 1948-1985: Epidemiology, factors of significance for long-term survival, and causes of death in 179 patients
15. Long-term survival in patients with hereditary hemochromatosis
16. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
17. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
18. Factors affecting glucose tolerance in hereditary hemochromatosis
19. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis
20. Disease-related conditions in relatives of patients with hemochromatosis
21. Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping
22. Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F
23. Severity of iron overload in hemochromatosis: Effect of volunteer blood donation before diagnosis
24. A population-based study of the clinical expression of the hemochromatosis gene
25. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression
26. The effect of HFE genotypes on measurement of iron overload in patients attending a health appraisal clinic
27. Non-expressing C282Y homozygotes for hemochromatosis: Minority or majority of cases?
28. The significance of hemochromatosis gene mutations in the general population: Implications for screening
29. Population-based screening for hemochromatosis using phenotypic and DNA testign among employees of health maintenance organizations in Springfield, Missouri
30. Genes that modify the hemochromatosis phenotype in mice
31. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment
32. Penetrance of the 845G to A (C282Y) HFE hereditary hemochromatosis mutation
33. Population screening for hemochromatosis